Hikma has $400 million to make acquisitions this year
This article was originally published in Scrip
Executive Summary
Hikma Pharmaceuticals is in a position to carry out acquisitions worth up to $400 million in total this year, CEO Said Darwazah has told Scrip. "In 2009 we were actively engaged with certain companies and we should see those talks come to fruition this year," he added.